Cite
HARVARD Citation
Kalra, P. et al. (2022). Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 400 (10369), pp. 2199-2209. [Online].